Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...

Solid 2024 performance; executing on plan to accelerate growth ...

A sales drop in the mid-single digits in Kraft Heinz’s fourth quarter and in the low single digits for the year sent the CPG giant’s stock tumbling, but executives have a plan to claw back losses – th ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...

In yet another remarkable annual performance, Dubai welcomed 18.72 million international overnight visitors from January to December 2024, a 9% year-over-year increase that surpasses the previous ...

With the targets of the Vision 2026 plan interrupted by the pandemic and changes in China consumer appetite, leading to weak 2024 earnings, Kose has revamped its focus. The key components of its ...

Data is crucial, but context is king - being able to offer both is the tricky bit, but HubSpot reckons it has the answer.

NCSOFT restructures for post-Lineage era amid record losses and new IP focus NCSOFTs major transformation plans signal a ...

On the morning and afternoon of Jan. 28, a few extra cars were spotted by 7723 Kingston Pike across from West Town Mall. This was not rush hour in the traditional sense, although it involved some ...

From creating visionary content to optimizing for LLMs, unpack key tactics influencing industry conversations and fueling new ...

BlackLine, Inc. (Nasdaq: BL), today announced financial results for the fourth quarter and full year ended December 31, 2024. "We believe our recent user ...

Kim Rogers has long taught business classes at Ashland High, but her retirement at the year's end will mean a loss of three ...